Ursolic acid interaction with transcription factors BRAF, V600E, and V600K: a computational approach towards new potential melanoma treatments.

Context: Melanoma is one of the cancers with the highest mortality rate for its ability to metastasize. Several targets have undergone investigation for the development of drugs against this pathology. One of the main targets is the kinase BRAF (RAF, rapidly accelerated fibrosarcoma).

In silico study suggests potential drugs that target CD151 to treat breast cancer and glioblastoma.

Recently tetraspanin CD151 has been identified as an important biological target involved in metastatic processes which include cell adhesion, tumor progression processes, and so forth in different types of cancers, such as breast cancer and glioblastoma. This in Silico study considered 1603 compounds from the Food and Drug Administration database, after performing an ADMET analysis; we selected 853 ligands, which were used for docking analysis. The most promising ligands were selected from docking studies, based on two criteria: (a) showed lowest affinity to the CD151 protein and (b) they interact with the QRD motif, located in the second extracellular loop.

Photocatalytic activity of silver nanoparticles@cellulose nanocomposites, from pistachio husk, in the toxic azo commercial dye degradation.

In this work, an over-the-counter commercial dye, containing direct blue 151 in its composition, which is also discarded without any environmental regulation, was efficiency photodegraded using a green chemistry-synthesized nanocomposites type silver nanoparticles (AgNPs) supported on pistachio husk (PH). The green synthesis (GS) of the nanocomposites was carried out using the Anemopsis californica leaf extract (ExAc) as a reducing-stabilizing agent (AgNPs/ExAc-PH), for the first time. The presence of AgNPs on the nanocomposite surface was corroborated by field emission transmission electron microscope (FE-TEM), X-ray diffraction (XRD), and thermogravimetric analysis (TGA).